PL2723764T3 - Domeny wiążące skierowane przeciwko kompleksom GPCR: białko G i związane z nimi zastosowania - Google Patents
Domeny wiążące skierowane przeciwko kompleksom GPCR: białko G i związane z nimi zastosowaniaInfo
- Publication number
- PL2723764T3 PL2723764T3 PL12730478T PL12730478T PL2723764T3 PL 2723764 T3 PL2723764 T3 PL 2723764T3 PL 12730478 T PL12730478 T PL 12730478T PL 12730478 T PL12730478 T PL 12730478T PL 2723764 T3 PL2723764 T3 PL 2723764T3
- Authority
- PL
- Poland
- Prior art keywords
- directed against
- binding domains
- protein complexes
- domains directed
- uses derived
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4722—G-proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161571159P | 2011-06-21 | 2011-06-21 | |
| EP11181357 | 2011-09-15 | ||
| EP12730478.0A EP2723764B1 (en) | 2011-06-21 | 2012-06-21 | Binding domains directed against gpcr: g protein complexes and uses derived thereof |
| PCT/EP2012/062036 WO2012175643A2 (en) | 2011-06-21 | 2012-06-21 | Binding domains directed against gpcr:g protein complexes and uses derived thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2723764T3 true PL2723764T3 (pl) | 2018-05-30 |
Family
ID=47423019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12730478T PL2723764T3 (pl) | 2011-06-21 | 2012-06-21 | Domeny wiążące skierowane przeciwko kompleksom GPCR: białko G i związane z nimi zastosowania |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US9695227B2 (pl) |
| EP (3) | EP2723764B1 (pl) |
| JP (2) | JP6164535B2 (pl) |
| CN (2) | CN107857810A (pl) |
| AU (1) | AU2012273987B2 (pl) |
| CA (1) | CA2839834A1 (pl) |
| DK (1) | DK2723764T3 (pl) |
| ES (1) | ES2662372T3 (pl) |
| HR (1) | HRP20180443T1 (pl) |
| HU (1) | HUE036982T2 (pl) |
| NO (1) | NO2723764T3 (pl) |
| PL (1) | PL2723764T3 (pl) |
| PT (1) | PT2723764T (pl) |
| WO (1) | WO2012175643A2 (pl) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201014715D0 (en) | 2010-09-06 | 2010-10-20 | Vib Vzw | Nanobodies stabilizing functional conformational states of GPCRS |
| PT2723764T (pt) | 2011-06-21 | 2018-03-09 | Univ Leland Stanford Junior | Domínios de ligação dirigidos contra complexos gpcr:proteína g e suas utilizações derivadas |
| WO2014001557A1 (en) | 2012-06-28 | 2014-01-03 | Ucb Pharma S.A. | A method for identifying compounds of therapeutic interest |
| EP4610368B1 (en) | 2013-08-05 | 2026-02-04 | Twist Bioscience Corporation | De novo synthesized gene libraries |
| EP3164415B1 (en) * | 2014-07-04 | 2024-10-30 | INSERM - Institut National de la Santé et de la Recherche Médicale | Anti- mglur2 conformational single domain antibodies and uses thereof |
| WO2016067094A2 (en) | 2014-10-27 | 2016-05-06 | King Abdullah University Of Science And Technology | Methods and systems for identifying ligand-protein binding sites |
| WO2016126882A1 (en) | 2015-02-04 | 2016-08-11 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
| US9981239B2 (en) | 2015-04-21 | 2018-05-29 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
| IL258164B (en) | 2015-09-18 | 2022-09-01 | Twist Bioscience Corp | Methods for modulating protein and cellular activity and method for nucleic acid synthesis |
| CN108698012A (zh) | 2015-09-22 | 2018-10-23 | 特韦斯特生物科学公司 | 用于核酸合成的柔性基底 |
| CN115920796A (zh) | 2015-12-01 | 2023-04-07 | 特韦斯特生物科学公司 | 功能化表面及其制备 |
| CN105802970A (zh) * | 2016-05-30 | 2016-07-27 | 东北师范大学 | 靶向沉默Gβ1的shRNA |
| SG11201901563UA (en) | 2016-08-22 | 2019-03-28 | Twist Bioscience Corp | De novo synthesized nucleic acid libraries |
| JP6871364B2 (ja) | 2016-09-21 | 2021-05-12 | ツイスト バイオサイエンス コーポレーション | 核酸に基づくデータ保存 |
| CN107037116B (zh) * | 2016-12-01 | 2019-04-23 | 白波 | 检测gpcr之间相互作用及其交界面的方法 |
| AU2017378492B2 (en) | 2016-12-16 | 2022-06-16 | Twist Bioscience Corporation | Variant libraries of the immunological synapse and synthesis thereof |
| EP4556433A3 (en) | 2017-02-22 | 2025-08-06 | Twist Bioscience Corporation | Nucleic acid based data storage |
| WO2018170169A1 (en) | 2017-03-15 | 2018-09-20 | Twist Bioscience Corporation | Variant libraries of the immunological synapse and synthesis thereof |
| CN111566209B (zh) | 2017-06-12 | 2024-08-30 | 特韦斯特生物科学公司 | 无缝核酸装配方法 |
| WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| EP3681906A4 (en) * | 2017-09-11 | 2021-06-09 | Twist Bioscience Corporation | GPCR-BINDING PROTEINS AND THEIR SYNTHESIS |
| KR102889470B1 (ko) | 2017-10-20 | 2025-11-21 | 트위스트 바이오사이언스 코포레이션 | 폴리뉴클레오타이드 합성을 위한 가열된 나노웰 |
| WO2019086548A1 (en) | 2017-10-31 | 2019-05-09 | Vib Vzw | Novel antigen-binding chimeric proteins and methods and uses thereof |
| CN111050856B (zh) * | 2017-12-21 | 2024-12-31 | 弗门尼舍有限公司 | 鉴定气味剂受体的正变构调节剂的方法 |
| CA3088911A1 (en) | 2018-01-04 | 2019-07-11 | Twist Bioscience Corporation | Dna-based storage device and method for synthesizing polynucleotides using the device |
| WO2019155041A1 (en) * | 2018-02-12 | 2019-08-15 | Vib Vzw | Gβγ COMPLEX ANTIBODIES AND USES THEREOF |
| CN108586620B (zh) * | 2018-05-10 | 2021-11-23 | 山东大学 | 筛选昆虫性信息素受体的配体的传感器分子以及筛选方法 |
| WO2019222706A1 (en) | 2018-05-18 | 2019-11-21 | Twist Bioscience Corporation | Polynucleotides, reagents, and methods for nucleic acid hybridization |
| FR3084365B1 (fr) * | 2018-07-27 | 2020-10-23 | Cisbio Bioassays | Anticorps a domaine unique qui se lient a la proteine g alpha |
| EP3898664A1 (en) * | 2018-12-21 | 2021-10-27 | Vib Vzw | Fusion proteins comprising a cytokine and scaffold protein |
| CA3124980A1 (en) | 2018-12-26 | 2020-07-02 | Twist Bioscience Corporation | Highly accurate de novo polynucleotide synthesis |
| FR3092172B1 (fr) * | 2019-01-30 | 2021-02-12 | Cisbio Bioassays | Méthode pour mesurer la modulation de l’activation d’un récepteur couplé à une protéine G avec des analogues du GTP |
| JP2022521551A (ja) | 2019-02-26 | 2022-04-08 | ツイスト バイオサイエンス コーポレーション | Ｇｌｐ１受容体の変異体核酸ライブラリ |
| CN113785057A (zh) | 2019-02-26 | 2021-12-10 | 特韦斯特生物科学公司 | 用于抗体优化的变异核酸文库 |
| EP3963329A1 (en) | 2019-04-29 | 2022-03-09 | Confo Therapeutics N.V. | Screening methods and assays for use with transmembrane proteins, in particular with gpcrs |
| US12123814B1 (en) * | 2019-06-14 | 2024-10-22 | Pierce Biotechnology, Inc. | G- protein coupled receptor extraction formulations |
| EP3986437A4 (en) | 2019-06-18 | 2023-06-07 | Musc Foundation for Research Development | COMPOSITIONS TARGETED AGAINST THE NUCLEOTIDE-FREE STATE OF RAS AND METHODS FOR BLOCKING ONCOGENIC SIGNALING AND TRANSFORMATION |
| AU2020298294A1 (en) | 2019-06-21 | 2022-02-17 | Twist Bioscience Corporation | Barcode-based nucleic acid sequence assembly |
| WO2021061842A1 (en) | 2019-09-23 | 2021-04-01 | Twist Bioscience Corporation | Variant nucleic acid libraries for single domain antibodies |
| US12091777B2 (en) | 2019-09-23 | 2024-09-17 | Twist Bioscience Corporation | Variant nucleic acid libraries for CRTH2 |
| BR112022011235A2 (pt) | 2019-12-09 | 2022-12-13 | Twist Bioscience Corp | Bibliotecas de variantes de ácido nucleico para receptores de adenosina |
| FR3106830B1 (fr) | 2020-01-30 | 2022-02-11 | Cisbio Bioassays | Anticorps anti-protéine G alpha |
| CA3190667A1 (en) | 2020-08-26 | 2022-03-03 | Aaron Sato | Methods and compositions relating to glp1r variants |
| WO2023154533A2 (en) * | 2022-02-14 | 2023-08-17 | Twist Bioscience Corporation | Combinatorial dna assembly for multispecific antibodies |
| WO2023159144A2 (en) * | 2022-02-17 | 2023-08-24 | The Regents Of The University Of Michigan | G-protein coupled receptor assay |
| CN114702570B (zh) * | 2022-03-23 | 2022-12-06 | 山东大学 | aGPCR拮抗剂 |
| WO2024083843A1 (en) | 2022-10-18 | 2024-04-25 | Confo Therapeutics N.V. | Amino acid sequences directed against the melanocortin 4 receptor and polypeptides comprising the same for the treatment of mc4r-related diseases and disorders |
| US11862295B1 (en) | 2022-11-08 | 2024-01-02 | United Arab Emirates University | Method of classifying conformers |
| CN116425888B (zh) * | 2023-04-24 | 2024-11-05 | 徐州医科大学 | 一种多肽tat-v2r1c及其应用 |
| US12176075B1 (en) | 2023-11-14 | 2024-12-24 | United Arab Emirates University | Method of matching conformers of different molecules |
| WO2025129064A1 (en) * | 2023-12-15 | 2025-06-19 | Eve Bio, Llc | Spliced rna barcodes for multiplexed cell-based high throughput screening |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
| EP4620523A1 (en) * | 2024-03-22 | 2025-09-24 | Genome Research Limited | Mutants of the beta2-adrenergic receptor with altered activity and their use in disease treatment. |
| JP2025167890A (ja) * | 2024-04-26 | 2025-11-07 | 国立大学法人 東京大学 | 標的タンパク質に付加されるためのタンパク質 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1498427B1 (en) | 1992-08-21 | 2009-12-16 | Vrije Universiteit Brussel | Immunoglobulins devoid of light chains |
| US5721121A (en) | 1995-06-06 | 1998-02-24 | Genentech, Inc. | Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein |
| BR9907241A (pt) | 1998-01-26 | 2000-10-17 | Unilever Nv | Biblioteca de expressão, processo para preparar a mesma, uso de uma fonte não imunizada de sequências de ácido nucleico, e, processos para preparar fragmentos de anticorpos e, para preparar um anticorpo |
| WO2000043507A1 (en) | 1999-01-19 | 2000-07-27 | Unilever Plc | Method for producing antibody fragments |
| CA2380443C (en) | 2000-05-26 | 2013-03-12 | Ginette Dubuc | Single-domain antigen-binding antibody fragments derived from llama antibodies |
| US7294472B2 (en) * | 2001-03-14 | 2007-11-13 | Caden Biosciences | Method for identifying modulators of G protein coupled receptor signaling |
| US7208279B2 (en) | 2001-03-14 | 2007-04-24 | Caden Biosciences, Inc. | Method for identifying inhibitors of G protein coupled receptor signaling |
| GB0110029D0 (en) | 2001-04-24 | 2001-06-13 | Grosveld Frank | Transgenic animal |
| WO2004035614A1 (en) * | 2001-07-11 | 2004-04-29 | Karo Bio Ab | Synthetic or partially purified peptides which can bind to specific subunits of g proteins and uses thereof |
| EP1433793A4 (en) | 2001-09-13 | 2006-01-25 | Inst Antibodies Co Ltd | METHOD FOR CREATING A CAMEL ANTIBODY LIBRARY |
| JP2005289809A (ja) | 2001-10-24 | 2005-10-20 | Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) | 突然変異重鎖抗体 |
| GB0228210D0 (en) | 2002-12-03 | 2003-01-08 | Babraham Inst | Single chain antibodies |
| DE60329627D1 (de) | 2002-12-31 | 2009-11-19 | Nektar Therapeutics Al Corp | Hydrolysestabile maleimidendgruppen-enthaltende polymere |
| US9029097B2 (en) * | 2005-02-16 | 2015-05-12 | Universite De Montreal | Biosensors for monitoring receptor-mediated G-protein activation |
| AU2007285695B2 (en) | 2006-08-18 | 2012-05-24 | Ablynx N.V. | Amino acid sequences directed against IL-6R and polypeptides comprising the same for the treatment of diseases and disorders associated with IL-6-mediated signalling |
| WO2009051633A1 (en) | 2007-10-15 | 2009-04-23 | The Board Of Trustees Of The Leland Stanford Junior University | Gpcr crystalization method using an antibody |
| AU2009248049B2 (en) * | 2008-05-16 | 2015-07-23 | Ablynx N.V. | Amino acid sequences directed against CXCR4 and other GPCRs and compounds comprising the same |
| WO2009147196A1 (en) | 2008-06-04 | 2009-12-10 | Vib Vzw | Hiv-rev-multimerization inhibiting nanobodies |
| EP2352764B1 (en) * | 2008-10-14 | 2018-03-28 | Ablynx N.V. | AMINO ACID SEQUENCES TARGETING HUMAN CD4 and CXCR4, CCR5, TLR4, ALPHAV INTEGRIN, BETA3-INTEGRIN,BETA1-INTEGRIN, HUMAN ALPHA2-INTEGRIN, CD81, SR-BI, CLAUDIN-1, CLAUDIN-6 AND/OR CLAUDIN-9, RESPECTIVELY, AND NEUTRALIZING VIRAL ENTRY |
| DK2367840T3 (en) | 2008-12-08 | 2015-10-12 | Complix N V | SINGLE CHAIN antiparallel coiled-coil PROTEINS |
| GB201014715D0 (en) | 2010-09-06 | 2010-10-20 | Vib Vzw | Nanobodies stabilizing functional conformational states of GPCRS |
| US8765414B2 (en) | 2011-03-15 | 2014-07-01 | The Board Of Trustees Of The Leland Stanford Junior University | GPCR fusion protein containing an N-terminal autonomously folding stable domain, and crystals of the same |
| PT2723764T (pt) | 2011-06-21 | 2018-03-09 | Univ Leland Stanford Junior | Domínios de ligação dirigidos contra complexos gpcr:proteína g e suas utilizações derivadas |
-
2012
- 2012-06-21 PT PT127304780T patent/PT2723764T/pt unknown
- 2012-06-21 WO PCT/EP2012/062036 patent/WO2012175643A2/en not_active Ceased
- 2012-06-21 DK DK12730478.0T patent/DK2723764T3/en active
- 2012-06-21 CN CN201710728087.8A patent/CN107857810A/zh active Pending
- 2012-06-21 US US14/129,100 patent/US9695227B2/en active Active
- 2012-06-21 EP EP12730478.0A patent/EP2723764B1/en active Active
- 2012-06-21 HU HUE12730478A patent/HUE036982T2/hu unknown
- 2012-06-21 AU AU2012273987A patent/AU2012273987B2/en active Active
- 2012-06-21 CA CA2839834A patent/CA2839834A1/en active Pending
- 2012-06-21 HR HRP20180443TT patent/HRP20180443T1/hr unknown
- 2012-06-21 EP EP23193788.9A patent/EP4282882A3/en active Pending
- 2012-06-21 EP EP17209368.4A patent/EP3345919A1/en active Pending
- 2012-06-21 JP JP2014516358A patent/JP6164535B2/ja active Active
- 2012-06-21 ES ES12730478.0T patent/ES2662372T3/es active Active
- 2012-06-21 NO NO12730478A patent/NO2723764T3/no unknown
- 2012-06-21 CN CN201280040585.9A patent/CN104053667B/zh active Active
- 2012-06-21 PL PL12730478T patent/PL2723764T3/pl unknown
-
2017
- 2017-02-16 JP JP2017026632A patent/JP2017127306A/ja active Pending
- 2017-05-01 US US15/583,540 patent/US10626154B2/en active Active
-
2020
- 2020-04-17 US US16/852,235 patent/US12252521B2/en active Active
-
2024
- 2024-11-26 US US18/960,784 patent/US20250171510A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017127306A (ja) | 2017-07-27 |
| JP6164535B2 (ja) | 2017-07-19 |
| US20140275487A1 (en) | 2014-09-18 |
| CN104053667A (zh) | 2014-09-17 |
| EP4282882A3 (en) | 2024-03-06 |
| AU2012273987B2 (en) | 2017-01-05 |
| US9695227B2 (en) | 2017-07-04 |
| EP2723764B1 (en) | 2017-12-27 |
| EP3345919A1 (en) | 2018-07-11 |
| US20250171510A1 (en) | 2025-05-29 |
| NO2723764T3 (pl) | 2018-05-26 |
| HUE036982T2 (hu) | 2018-08-28 |
| US20200239534A1 (en) | 2020-07-30 |
| ES2662372T3 (es) | 2018-04-06 |
| CN104053667B (zh) | 2017-09-15 |
| PT2723764T (pt) | 2018-03-09 |
| US12252521B2 (en) | 2025-03-18 |
| CA2839834A1 (en) | 2012-12-27 |
| CN107857810A (zh) | 2018-03-30 |
| DK2723764T3 (en) | 2018-03-12 |
| EP4282882A2 (en) | 2023-11-29 |
| US10626154B2 (en) | 2020-04-21 |
| WO2012175643A2 (en) | 2012-12-27 |
| JP2014525735A (ja) | 2014-10-02 |
| AU2012273987A1 (en) | 2014-01-30 |
| US20170253644A1 (en) | 2017-09-07 |
| EP2723764A2 (en) | 2014-04-30 |
| BR112013032451A2 (pt) | 2016-11-22 |
| WO2012175643A3 (en) | 2013-06-13 |
| HRP20180443T1 (hr) | 2018-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2723764T (pt) | Domínios de ligação dirigidos contra complexos gpcr:proteína g e suas utilizações derivadas | |
| IL271804A (en) | Mice producing binding proteins containing VL domains | |
| EP2655415A4 (en) | THREE VARIABLE DOMAIN LINK PROTEINS AND USES THEREOF | |
| IL254652B (en) | Unnatural albumin binding sites | |
| EP2654792A4 (en) | HALF IMMUNOGLOBULIN BINDING PROTEINS AND USES THEREOF | |
| ZA201504803B (en) | Prolactin receptor binding proteins and uses thereof | |
| IL222323A0 (en) | Tnf - alpha binding proteins | |
| IL230918A0 (en) | Modified proteins and peptides | |
| EP2638073A4 (en) | PROTEIN COMPLEXES FOR ANTIGEN BINDING, AND METHODS OF USE | |
| ZA201400525B (en) | Rspo binding agents and uses thereof | |
| ZA201209091B (en) | Serum albumin binding molecules | |
| ZA201205624B (en) | Cd127 binding proteins | |
| ZA201403570B (en) | Binding molecules specific for her3 and uses thereof | |
| ZA201500872B (en) | Rspo3 binding agents and uses thereof | |
| SG2014010334A (en) | Fn14 binding proteins and uses thereof | |
| EP2911694A4 (en) | ANTI-INFECTIOUS BINDING PROTEINS THAT BIND TO AIP2 | |
| SG10201503080XA (en) | Eif4e binding peptides | |
| GB201103961D0 (en) | Binding polypeptides | |
| AU2012901273A0 (en) | CD43 binding proteins and uses thereof | |
| GB201121233D0 (en) | Modified proteins and peptides | |
| GB201121226D0 (en) | Modified proteins and peptides | |
| GB201003906D0 (en) | Binding polypeptides | |
| HK1190416A (en) | Tri-variable domain binding proteins and uses thereof |